Are Accurins the cure for Aurora kinase inhibitors?
- PMID: 26865564
- DOI: 10.1126/scitranslmed.aaf1417
Are Accurins the cure for Aurora kinase inhibitors?
Abstract
A nanoparticle formulation of an Aurora B inhibitor increases antitumor efficacy and reduces toxicity, which may be a precedent for the use of this technology with other small molecules (Ashton et al., this issue).
Copyright © 2016, American Association for the Advancement of Science.
Comment on
-
Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo.Sci Transl Med. 2016 Feb 10;8(325):325ra17. doi: 10.1126/scitranslmed.aad2355. Sci Transl Med. 2016. PMID: 26865565
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources